{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:40Z","timestamp":1786993720696,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:00:00Z","timestamp":1736035200000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.lfs.2023.122395","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T19:29:34Z","timestamp":1704310174000},"page":"122395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Discovery of novel inhibitors of histone deacetylase 6: Structure-based virtual screening, molecular dynamics simulation, enzyme inhibition and cell viability assays"],"prefix":"10.1016","volume":"338","author":[{"given":"Abdullahi Ibrahim","family":"Uba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Hryb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mursalin","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Bui-Linh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancarlo","family":"Atienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Misbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2023.122395_bb0005","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/emboj\/19.6.1176","article-title":"Acetylation: a regulatory modification to rival phosphorylation?","volume":"19","author":"Kouzarides","year":"2000","journal-title":"EMBO J."},{"issue":"5968","key":"10.1016\/j.lfs.2023.122395_bb0010","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.1187159","article-title":"Cell biology. Rise of the rival","volume":"327","author":"Norvell","year":"2010","journal-title":"Science"},{"issue":"5942","key":"10.1016\/j.lfs.2023.122395_bb0015","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.lfs.2023.122395_bb0020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/pro.2469","article-title":"Crystal structure of the histone lysine specific demethylase LSD1 complexed with tetrahydrofolate","volume":"23","author":"Luka","year":"2014","journal-title":"Protein Sci."},{"issue":"5968","key":"10.1016\/j.lfs.2023.122395_bb0025","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.1179689","article-title":"Regulation of cellular metabolism by protein lysine acetylation","volume":"327","author":"Zhao","year":"2010","journal-title":"Science"},{"issue":"5968","key":"10.1016\/j.lfs.2023.122395_bb0030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.1179687","article-title":"Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.lfs.2023.122395_bb0035","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrm3841","article-title":"The growing landscape of lysine acetylation links metabolism and cell signalling","volume":"15","author":"Choudhary","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.lfs.2023.122395_bb0040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"issue":"40","key":"10.1016\/j.lfs.2023.122395_bb0045","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1038\/sj.onc.1207893","article-title":"Histone deacetylase inhibitors specifically kill nonproliferating tumour cells","volume":"23","author":"Burgess","year":"2004","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nm1160","article-title":"Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway","volume":"11","author":"Insinga","year":"2004","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.122395_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2023.122395_bb0060","first-page":"769","article-title":"Expression profile of class I histone deacetylases in human cancer tissues","volume":"18","author":"Nakagawa","year":"2007","journal-title":"Oncol. Rep."},{"issue":"23","key":"10.1016\/j.lfs.2023.122395_bb0065","first-page":"8492","article-title":"The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells","volume":"61","author":"Munster","year":"2001","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.122395_bb0070","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.18632\/oncotarget.13764","article-title":"Suberoylanilide hydroxamic acid-induced specific epigenetic regulation controls leptin-induced proliferation of breast cancer cell lines","volume":"8","author":"Feng","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.lfs.2023.122395_bb0075","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","article-title":"Three proteins define a class of human histone deacetylases related to yeast Hda1p","volume":"96","author":"Grozinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.lfs.2023.122395_bb0080","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1074\/jbc.C500241200","article-title":"Two catalytic domains are required for protein deacetylation","volume":"281","author":"Zhang","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbrc.2005.12.144","article-title":"Characterization of the two catalytic domains in histone deacetylase 6","volume":"341","author":"Zou","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"21","key":"10.1016\/j.lfs.2023.122395_bb0090","doi-asserted-by":"crossref","first-page":"13425","DOI":"10.1073\/pnas.172511699","article-title":"Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes","volume":"99","author":"Hook","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6887","key":"10.1016\/j.lfs.2023.122395_bb0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.lfs.2023.122395_bb0100","doi-asserted-by":"crossref","first-page":"741+","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0105","doi-asserted-by":"crossref","first-page":"12433","DOI":"10.1038\/s41598-023-33889-3","article-title":"HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma","volume":"13","author":"Garrett","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90527-6","article-title":"HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation","volume":"11","author":"Alothaim","year":"2021","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.lfs.2023.122395_bb0120","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/1078-0432.CCR-16-2526","article-title":"Ricolinostat, the first selective histone deacetylase 6 inhibitor, in combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma","volume":"23","author":"Vogl","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"46","key":"10.1016\/j.lfs.2023.122395_bb0125","doi-asserted-by":"crossref","first-page":"80109","DOI":"10.18632\/oncotarget.19019","article-title":"HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer","volume":"8","author":"Hideshima","year":"2017","journal-title":"Oncotarget"},{"issue":"46","key":"10.1016\/j.lfs.2023.122395_bb0130","doi-asserted-by":"crossref","first-page":"13162","DOI":"10.1073\/pnas.1608067113","article-title":"Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma","volume":"113","author":"Hideshima","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-004-1668-2","article-title":"Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis","volume":"90","author":"Krusche","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.lfs.2023.122395_bb0140","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.lungcan.2011.02.019","article-title":"Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung","volume":"74","author":"Minamiya","year":"2011","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.lfs.2023.122395_bb0145","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1158\/1078-0432.CCR-07-0990","article-title":"Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo","volume":"14","author":"Weichert","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.122395_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000111106","article-title":"Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma","volume":"72","author":"Rikimaru","year":"2007","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.lfs.2023.122395_bb0155","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1470-2045(08)70004-4","article-title":"Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis","volume":"9","author":"Weichert","year":"2008","journal-title":"Lancet Oncol."},{"issue":"19","key":"10.1016\/j.lfs.2023.122395_bb0160","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1038\/sj.onc.1202043","article-title":"Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein","volume":"16","author":"David","year":"1998","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.lfs.2023.122395_bb0165","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1128\/MCB.00494-07","article-title":"Role for histone deacetylase 1 in human tumor cell proliferation","volume":"27","author":"Senese","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122395_bb0170","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ccr.2010.10.022","article-title":"Hdac3 is essential for the maintenance of chromatin structure and genome stability","volume":"18","author":"Bhaskara","year":"2010","journal-title":"Cancer Cell"},{"issue":"42","key":"10.1016\/j.lfs.2023.122395_bb0175","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0404603101","article-title":"Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor","volume":"101","author":"Vannini","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1078-0432.CCR-08-0684","article-title":"Histone deacetylase 8 in neuroblastoma tumorigenesis","volume":"15","author":"Oehme","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.lfs.2023.122395_bb0185","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1091\/mbc.e08-02-0139","article-title":"HDAC4 promotes growth of colon cancer cells via repression of p21","volume":"19","author":"Wilson","year":"2008","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.lfs.2023.122395_bb0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/onc.2008.371","article-title":"HDAC4 represses p21(WAF1\/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism","volume":"28","author":"Mottet","year":"2009","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijc.20395","article-title":"Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients","volume":"112","author":"Osada","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2023.122395_bb0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2559.2008.03109.x","article-title":"Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma","volume":"53","author":"Marquard","year":"2008","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.lfs.2023.122395_bb0205","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2023.122395_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"issue":"28","key":"10.1016\/j.lfs.2023.122395_bb0215","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1038\/sj.onc.1208646","article-title":"Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer","volume":"24","author":"Saji","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.lfs.2023.122395_bb0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","article-title":"HDAC6 modulates cell motility by altering the acetylation level of cortactin","volume":"27","author":"Zhang","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2023.122395_bb0225","series-title":"Prostate Cancer","first-page":"443","article-title":"HDAC6 regulation of androgen signaling in prostate cancer","author":"Ai","year":"2013"},{"issue":"39","key":"10.1016\/j.lfs.2023.122395_bb0230","doi-asserted-by":"crossref","first-page":"28021","DOI":"10.1074\/jbc.M113.498758","article-title":"Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression","volume":"288","author":"Song","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"37","key":"10.1016\/j.lfs.2023.122395_bb0235","doi-asserted-by":"crossref","first-page":"59388","DOI":"10.18632\/oncotarget.10673","article-title":"HDAC10 promotes lung cancer proliferation via AKT phosphorylation","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.lfs.2023.122395_bb0240","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/ijc.27876","article-title":"HDAC11 is a novel drug target in carcinomas","volume":"132","author":"Deubzer","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0250","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1080\/14756366.2019.1613987","article-title":"Structure-based design generated novel hydroxamic acid based preferential HDAC6 lead inhibitor with on-target cytotoxic activity against primary choroid plexus carcinoma","volume":"34","author":"Kassab","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2023.122395_bb0255","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1080\/07391102.2019.1652687","article-title":"Structure-based design of selective histone deacetylase 6 zinc binding groups","volume":"38","author":"Alves Avelar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.lfs.2023.122395_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110454","article-title":"Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells","volume":"129","author":"Dawood","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"13","key":"10.1016\/j.lfs.2023.122395_bb0265","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1080\/07391102.2016.1231084","article-title":"Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations","volume":"35","author":"Sixto-L\u00f3pez","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.lfs.2023.122395_bb0270","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.compbiolchem.2018.05.004","article-title":"Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: structure-based virtual screening, molecular docking and dynamics simulation studies","volume":"75","author":"Uba","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122395_bb0275","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.compbiolchem.2018.10.016","article-title":"Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6","volume":"77","author":"Uba","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122395_bb0280","first-page":"1","article-title":"Identification of HDAC6 selective inhibitors: pharmacophore based virtual screening, molecular docking and molecular dynamics simulation","author":"Yan","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.lfs.2023.122395_bb0285","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.lfs.2023.122395_bb0290","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.lfs.2023.122395_bb0295","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.lfs.2023.122395_bb0300","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1002\/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U","article-title":"The design of leadlike combinatorial libraries","volume":"38","author":"Teague","year":"1999","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0305","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"10.1016\/j.lfs.2023.122395_bb0310","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jcc.10402","article-title":"Partial rigid-body dynamics in NPT, NPAT and NPgammaT ensembles for proteins and membranes","volume":"25","author":"Ikeguchi","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"15","key":"10.1016\/j.lfs.2023.122395_bb0315","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/jcc.21237","article-title":"MILCH SHAKE: an efficient method for constraint dynamics applied to alkanes","volume":"30","author":"Bailey","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2023.122395_bb0320","doi-asserted-by":"crossref","first-page":"54101","DOI":"10.1063\/1.1839571","article-title":"Gaussian Split Ewald: a fast Ewald mesh method for molecular simulation","volume":"122","author":"Shan","year":"2005","journal-title":"J. Chem. Phys."},{"issue":"4","key":"10.1016\/j.lfs.2023.122395_bb0325","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1063\/1.472005","article-title":"Molecular dynamics with multiple time scales: the selection of efficient reference system propagators","volume":"105","author":"Stuart","year":"1996","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.lfs.2023.122395_bb0330","series-title":"Proceedings of the 2006 ACM\/IEEE conference on Supercomputing","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","volume":"84","author":"Bowers","year":"2006"},{"issue":"10","key":"10.1016\/j.lfs.2023.122395_bb0335","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"52","key":"10.1016\/j.lfs.2023.122395_bb0340","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1021\/jp982533o","article-title":"Generalized born model based on a surface integral formulation","volume":"102","author":"Ghosh","year":"1998","journal-title":"J. Phys. Chem. B"},{"issue":"4","key":"10.1016\/j.lfs.2023.122395_bb0345","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"issue":"31","key":"10.1016\/j.lfs.2023.122395_bb0350","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.lfs.2023.122395_bb0355","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.lfs.2023.122395_bb0360","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"7","key":"10.1016\/j.lfs.2023.122395_bb0365","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jmgm.2007.10.007","article-title":"Identification of ligand features essential for HDACs inhibitors by pharmacophore modeling","volume":"26","author":"Chen","year":"2008","journal-title":"J. Mol. Graph. Model."},{"issue":"7","key":"10.1016\/j.lfs.2023.122395_bb0370","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1021\/jm101373a","article-title":"Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation","volume":"54","author":"Botta","year":"2011","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2023.122395_bb0375","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1016\/j.bmcl.2009.04.058","article-title":"Isoxazole moiety in the linker region of HDAC inhibitors adjacent to the Zn-chelating group: effects on HDAC biology and antiproliferative activity","volume":"19","author":"Tapadar","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.lfs.2023.122395_bb0380","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.sbi.2011.08.004","article-title":"Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes","volume":"21","author":"Lombardi","year":"2011","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0385","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1080\/14756366.2017.1417274","article-title":"Zinc binding groups for histone deacetylase inhibitors","volume":"33","author":"Zhang","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2023.122395_bb0390","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2023.122395_bb0395","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/1759-7714.12167","article-title":"Effects of histone deacetylase inhibitor trichostatin A combined with cisplatin on apoptosis of A549 cell line","volume":"6","author":"Zhang","year":"2015","journal-title":"Thoracic Cancer"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523010305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523010305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:15:13Z","timestamp":1758402913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523010305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":79,"alternative-id":["S0024320523010305"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122395","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel inhibitors of histone deacetylase 6: Structure-based virtual screening, molecular dynamics simulation, enzyme inhibition and cell viability assays","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122395"}}